** Deutsche Bank cuts German medical software company
Compugroup Medical COP1n.DE to "hold" from "buy", pointing to
some headwinds in H2 2024
** DB notes the company has abandoned its FY 2025 mid-term
targets and refrained from posting mid-term guidance
** Although FY 2024 guidance was reiterated, the broker
notes the management's comments on moving parts that are "not
fully under control"
** The brokerage forecasts some pressure in H2 2024, among
which tougher competition and uncertainties around execution,
which may prevent the company from achieving the mid-point of FY
2024 outlook
** Though DB has now more concerns on execution, it sees
upside potential for H2 2024, if the company delivers on its
plans
** Shares in Compugroup are down 2.6%, among worst
performers on the German small cap index .SDAXI
(Reporting by Amir Orusov)
((Amir.orusov@thomsonreuters.com))